Investigating the Efficacy of Probiotics in Enhancing Gastrointestinal and Immunological Health

Launched by WECARE PROBIOTICS CO., LTD. · Mar 13, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how effective a specific probiotic called Ligilactobacillus salivarius LS97 is in improving gut health and immune function in healthy adults. The study will compare this probiotic to a placebo, which is a substance that has no active ingredients, to see if it really makes a difference in these areas.

To participate in the trial, you should be between the ages of 65 and 74, and be willing to attend three follow-up visits. Participants will need to provide samples of blood, urine, and stool during the study. However, if you have certain health conditions, like serious digestive diseases or neurological issues, or if you've had specific treatments like chemotherapy recently, you may not be eligible to join. If you're interested and meet the criteria, you'll be helping researchers learn more about the potential health benefits of probiotics!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Willing to undergo 3 follow-up visits during the intervention period
• • 2. Be willing to provide blood, urine and stool samples 2 times during the intervention period
• • 3. Good eyesight, can read and write, can wear glasses
• • 4. Have good hearing and be able to hear and understand all instructions during the intervention
• Exclusion Criteria:
• • 1. Digestive diseases, mainly gastrointestinal diseases (celiac disease, ulcerative colitis, Crohn's disease)
• • 2. Have a serious neurological condition (epilepsy, stroke, severe head trauma, meningitis in the last 10 years, brain surgery, brain tumor prolonged coma - not including general anaesthesia)
• • 3. Have received/are receiving treatment for the following mental disorders: alcohol/drug/substance abuse dependence, schizophrenia psychosis, bipolar disorder
• • 4. Take medication for depression or low mood
• • 5. Internal organ failure (heart, liver or kidney failure, etc.)
• • 6. Have received radiation or chemotherapy in the past
• • 7. have undergone a general anesthesia procedure/procedure within the past three years, or plan to undergo a general anesthesia procedure/procedure within the next 3 months during this trial period
• • 8. Have had hepatitis (hepatitis B, hepatitis C), HIV or syphilis in the past